... Holding Co at an exhibition of pharmaceutical and medical products held in Shanghai. The company is buying Cardinal Health Inc's drug distribution business in China.JING WEI/FOR CHINA DAILY Chinese firm buys drug distribution unit of US-based Cardinal ... ( read original story ...)
Shanghai Pharma to buy Cardinal Health’s China business for $557m
Chinese state-owned drugmaker Shanghai Pharmaceuticals said on Wednesday it had agreed to pay for $557m for Cardinal Health Inc’s China business, one of the country’s largest drug distributors. Shanghai Pharmaceuticals said in a statement that the ... ( read original story ...)
Manulife AM launches wholly-owned investment business in Shanghai
SHANGHAI (Reuters) - Canadian asset manager Manulife Asset Management on Wednesday launched a wholly-owned investment business in Shanghai and welcomed Beijing’s steps to raise limits on foreign ownership in the finance sector. Last Friday, China said it ... ( read original story ...)
Shanghai’s state-owned businesses in 800 billion yuan push to restore city’s economy
Businesses controlled by Shanghai’s municipal government have pledged to plough 800 billion yuan (US$120.7 billion) annually into industries like hi-tech manufacturing in the next five years in the city’s latest push to regain its status as the ... ( read original story ...)
Manulife launches wholly-owned investment business in Shanghai
Canadian asset manager Manulife Asset Management on Wednesday launched a wholly-owned investment business in Shanghai and welcomed Beijing's steps to raise limits on foreign ownership in the finance sector. Last Friday, China said it planned to increase ... ( read original story ...)
Shanghai Pharma buys US Cardinal Health’s China business for $557 million
Deal gives the China business $1.2 billion enterprise value Shanghai Pharma keen to expand network nationwide Cardinal Health put business up for sale due to rule changes U.S. private-equity firm Warburg Pincus among bidders-sources Shanghai ... ( read original story ...)
Cardinal Health Signs Definitive Agreement to Sell its China Business to Shanghai Pharma
DUBLIN, Ohio, Nov. 14, 2017 — Cardinal Health (NYSE: CAH) today announced that it has signed a definitive agreement to sell its Cardinal Health China business to Shanghai Pharmaceuticals Holding Co., Ltd. (“Shanghai Pharma”) for $1.2 billion. ( read original story ...)